Abstract
Definitive treatment of Alzheimer’s disease (AD) will depend upon understanding the etiology and pathogenesis of this degenerative process. Techniques derived from studies of molecular genetics will identify individuals at high risk [1]. These studies may also characterize the molecular defect(s) derived from the genetic expression of the disease, but we view them as future developments without clinical application for 1 to 2 decades. Alternatively, a shorter-term progress in the understanding of basic alterations of neurotransmitters, neuromodulators and growth factors may lead to the development of ameliorative or palliative therapies that attenuate the expression of symptoms and possibly even slow the disease process [2].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
R.N. Rosenberg. Neurogenetics, Principles, and Practice. Raven Press, NY, Alzheimer’s disease, pp. 95–99 (1986).
E. Giacobini and R. Becker. 1988. Advances in therapy of Alzheimer’s disease. In: Familial Alzheimer’s Disease: Molecular Genetics, Clinical Perspectives, a Promising New Research. eds.G. Miner, J. Blass, R. Richter & J. Valentine. Marcel Dekker, Inc. New York (In press )
R.D. Terry, L.A. Hansen, R. DeTeresa et al. Senile dementia of the Alzheimer type without neocortical neurofibrillary tangles. J. Neurophathol. Exp. Neurol. 46, 262–268 (1987).
R. Katzman, R. Terry, R. DeTeresa, T. Brown, P. Davies, P. Fuld, X. Renbing and A. Peck. Clinical, pathological and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques. Ann. Neurol. 23, 138–144 (1988).
H.M. Wisniewski, G.S. Merz and R.I. Carp. Current hypothesis of the etiology and pathogenesis of senile dementia of the Alzheimer type. Interdiscipl. Topics Geront. 19, 45–53 (1985).
R.D. Terry. What, where and why are plaques. Alzheimer Disease and Associated Disorders 2: 223 (1988).
R.N. Rosenberg. Molecular genetics of Alzheimer’s disease; recent advances. Proceedings of the International Symposium on Alzheimer’s disease Abst., Kuopio, Finland (June, 1988 ).
D.A. Lewis, G.A. Higgins, W.G. Young, D. Goldgaber, D.C. Gajdusek, M.C. Wilson and J.H. Morrison. Distribution of precursor amyloid-0-protein messenger RNA in human cerebral cortex: Relationship to neurofibrillary tangles and neuritic plaques. Proc. Natl. Acad. Sci 85, 1691–1695 (1988).
M.R. Palmert, T.E. Golde, M.L. Cohen, D.M. Kovacs, R.E. Tanzi, J.F. Gusella, M.F. Usiak, L.H. Youngkin and S.G. Youngkin. Amyloid protein precursor messenger RNAs; differential expression in Alzheimer’s disease. Science, Vol. 241, pp. 1080–1084 (1988).
R.E. Tanzi, A.I. McClatchey, E.D. Lamperti, L. Villa-Komaroff, J.F. Gusella, R.L. Neve. Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer’s disease. Nature, 528–530 (1988).
N. Kitaguchi, Y. Takahashi, Y. Tokushima, S. Shiojiri and H. Ito. Novel precursor of Alzheimer’s disease amyloid protein shows protease inhibitory activity. Nature 331, 530–532 (1988).
R.E. Tanzi, J.F. Gusella, P.C. Watkins, G.A. Bruns, P. St. George-Hyslop, M.L. VanKeuren, D. Patterson, S. Pagan, D.M. Kurnit and R.L. Neve. Amyloid ß protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer ocus. Science 235, 880–884 (1987).
G. Bruce and G. Heinrich. The construction of human NGF expression vectors: Their potential role in the treatment of Alzheimer disease. 18th Annual Meeting Society for Neuroscience. Abst 331. 17 pp 827. (1988).
L. Olson, P. Enfors, T. Ebendal, P. Mouton, I. Stromberg and H. Persson. The establishment and use of stable cell lines that overexpress a transfected ß-NGF gene with studies in vitro, in oculo and intracranially. 18th Annual Meeting Society for Neuroscience Abst 276. 6 pp 684. (1988).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer Science+Business Media New York
About this chapter
Cite this chapter
Giacobini, E. (1990). Molecular Genetic Approaches in the Therapy of Alzheimer’s Disease. In: Lauder, J.M., Privat, A., Giacobini, E., Timiras, P.S., Vernadakis, A. (eds) Molecular Aspects of Development and Aging of the Nervous System. Advances in Experimental Medicine and Biology, vol 265. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-5876-4_26
Download citation
DOI: https://doi.org/10.1007/978-1-4757-5876-4_26
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-5878-8
Online ISBN: 978-1-4757-5876-4
eBook Packages: Springer Book Archive